<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Luper, Dyan C</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Anthrax 2001 – Lessons Learned: Clinical Laboratory and Beyond</style></title><secondary-title><style face="normal" font="default" size="100%">American Society for Clinical Laboratory Science</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2002-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">180-182</style></pages><doi><style  face="normal" font="default" size="100%">10.29074/ascls.15.3.180</style></doi><volume><style face="normal" font="default" size="100%">15</style></volume><issue><style face="normal" font="default" size="100%">3</style></issue><abstract><style  face="normal" font="default" size="100%">OBJECTIVE: Re-visit the 2001 anthrax outbreak to assess the ideas and concepts learned from the event as they relate to the illness and to bioterrorism preparedness.DATA SOURCES: Current literature.CONCLUSION: A multitude of lessons have been brought to light. The future of bioterrorism preparedness depends on whether those lessons are acknowledged and acted upon.ABBREVIATIONS: ASM = American Society for Microbiology; BT = bioterrorism; CDC = Centers for Disease Control; FEMA = Federal Emergency Management Administration; GAO = General Accounting Office; HHS = Health and Human Services; LRN = Laboratory Response Network; NCID/HIP = National Center for Infectious Disease/Hospital Information Program.</style></abstract></record></records></xml>